More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$1.09B
EPS
-1.4
P/E ratio
--
Price to sales
3.51
Dividend yield
--
Beta
1.646246
Previous close
$14.15
Today's open
$14.19
Day's range
$13.90 - $14.66
52 week range
$10.95 - $27.63
show more
CEO
Ramy Farid
Employees
850
Headquarters
New York, NY
Exchange
Nasdaq Global Select
Shares outstanding
74720724
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on May 18, 2026, the company granted (i) a non-statutory stock option to purchase 1,875 shares of the company's common stock to one newly hired employee and (ii) restricted stock units (RSUs) with respect to 18,766 shares of the company's common stock to seven newly hired employees. These grants were made pursuant to the company's 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of.
Business Wire • May 22, 2026

7 Healthcare AI Stocks Under $50 With Huge Upside Potential
Healthcare AI stocks have been hammered in 2026, with several names down 30% to 65% year to date even as their underlying platforms keep maturing.
24/7 Wall Street • May 18, 2026

Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha • May 14, 2026

Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
Seeking Alpha • May 6, 2026

Schrödinger Reports First Quarter 2026 Financial Results
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. announced financial results for the quarter ended March 31, 2026.
Business Wire • May 5, 2026

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates
Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to a loss of $0.82 per share a year ago.
Zacks Investment Research • May 5, 2026

Schrödinger to Participate in Upcoming Investor Conferences
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in the following conferences in May: BofA Securities 2026 Healthcare Conference: Fireside chat on Wednesday, May 13, 2026, at 5:20 p.m. E.T. RBC 2026 Global Healthcare Conference: Fireside chat on Tuesday, May 19, 2026 at 2:05 p.m. E.T. The live discussions can be accessed in the “Investors” section of Schrödinger's website and will be archived for approximately 90 days following the eve.
Business Wire • May 4, 2026

Schrödinger to Announce First Quarter 2026 Financial Results on May 5
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) will report its first quarter 2026 financial results on Tuesday, May 5, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the “Investors” section of Schrödinger's website and will be archived for approximately 90 days following the event. About Schrödinger Schrödinger is transforming molecular discovery with its computational platform, which.
Business Wire • Apr 21, 2026

Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
Seeking Alpha • Mar 23, 2026

Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Seeking Alpha • Mar 6, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Schrodinger Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.